| 摘要 |
The present disclosure relates to peptides for use in immunotherapy of FGF-5 expressing tumors. In one example, the peptide is an HLA-A3 epitope (such as NTYASPRFK). In another example, the peptide is an HLA-A2 epitope (such as MLSVLEIFAV). Methods are provided for using such peptides (and corresponding nucleic acid molecules), and variants, fragments or fusions thereof, to stimulate an immune response in a subject. The peptides (and corresponding nucleic acid molecules) disclosed herein can be formulated into pharmaceutical composition for administration to a subject.
|
